PLK1 and cancer: Our data suggest that combined inhibition of UBE2C and PLK1 can more significantly strongly attenuate the proliferation, migration, colony formation and other malignant phenotypes of pan-cancers while inducing more intense cell cycle arrest and apoptosis.